Trending News

Trump Administration Issues AI Action Plan and AI Executive Orders

Winning the Race: America’s AI Action Plan

Innovation Over Regulation – Trump Unveils America’s AI Action Plan

Caught in the Act: Practical and Legal Considerations When Executives’ Office Love Affair Exposed

Florida’s CHOICE Act Becomes Law, Enhancing Certain Non-Compete Agreements

Labor Secretary Lifts Abeyance on OFCCP Disability and Veteran Matters

In Case You Missed It: DOL Prohibited From Collecting Liquidated Damages in Wage & Hour Pre-Litigation Investigations

SEC’s New Concept Release on Foreign Private Issuer Standards

What Regulated Businesses Should Know About the Supreme Court’s Recent NEPA Decision

NEW ATDS BATTLEGROUND: Texas Passes HUGE NEW AMENDMENT to Its State Telemarketing Law Reviving The Risk of Autodialer Cases

GlobeNewswire Biotech

Website

www.globenewswire.com

Featured Biotech Press Releases From GlobeNewswire

Harvard Bioscience Schedules Fourth Quarter 2024 Earnings Conference Call for March 12, 2025 at 8:00 AM ET
Posted On Monday, February 24, 2025
United States FDA Approves NM8074 (Ruxoprubart) IND for Treating Dermatomyositis (DM): A Chronic Inflammatory Disorder of the Skin
Posted On Monday, February 24, 2025
OrganOx Completes $142 Million Equity Financing Led by HealthQuest Capital
Posted On Monday, February 24, 2025
Bright Green Corporation Announces the completion of its restructuring plan, withdraws from the Cannabis business and sets course on the production of all DEA Scheduled Controlled Substances
Posted On Monday, February 24, 2025
Coherus Management to Participate at the 45th Annual TD Cowen Health Care Conference
Posted On Monday, February 24, 2025
Editas Medicine to Announce Fourth Quarter/Full Year 2024 Financial Results and to Participate in Investor Conferences in March
Posted On Monday, February 24, 2025
Oragenics, Inc. Chief Medical Officer, Dr. James Kelly, Joins the Medical Board of The Leigh Steinberg Foundation for Concussion, Traumatic Brain Injury, and Brain Health
Posted On Monday, February 24, 2025
Myriad Genetics Partners with PATHOMIQ to add Artificial Intelligence Technology Platform to its Oncology Portfolio
Posted On Monday, February 24, 2025
Crinetics Pharmaceuticals Appoints Tobin Schilke as Chief Financial Officer
Posted On Monday, February 24, 2025
Inozyme Pharma to Present at the TD Cowen 45th Annual Health Care Conference
Posted On Monday, February 24, 2025
CytoDyn Announces Promising Survival Observations in mTNBC Patients Treated with Leronlimab
Posted On Monday, February 24, 2025
Biodexa Announces Allowance of U.S. Patent Covering Oral Rapamycin Nanoparticle Preparations (“eRapa”) and Use
Posted On Monday, February 24, 2025
FOXO TECHNOLOGIES, INC. ANNOUNCES EXECUTION OF A NON-BINDING ACQUISITION AGREEMENT FOR TWO ASSISTED-LIVING FACILITIES IN FLORIDA FOR A TOTAL CONSIDERATION OF $60 MILLION
Posted On Monday, February 24, 2025
Sionna Therapeutics to Present at the 45th Annual TD Cowen Health Care Conference
Posted On Monday, February 24, 2025
Phathom Pharmaceuticals to Report Fourth Quarter and Full Year 2024 Financial Results and Provide Business Update on Thursday, March 6, 2025
Posted On Monday, February 24, 2025
PDS Biotech Announces Circulating Tumor DNA Results for Versamune® HPV in IMMUNOCERV Trial Published in Clinical Cancer Research
Posted On Monday, February 24, 2025
aTyr Pharma to Present at the Leerink Partners Global Healthcare Conference
Posted On Monday, February 24, 2025
Calidi Biotherapeutics Announces Commencement of Recruitment for Multiple Dose CLD-101 Trial in Patients with Newly Diagnosed High Grade Glioma at Northwestern University Hospital
Posted On Monday, February 24, 2025
Cannara Announces Extension of BMO Credit Facility and Convertible Debenture to Enhance Financial Flexibility and Support Execution of its Long-Term Strategy
Posted On Monday, February 24, 2025
Plus Therapeutics Announces Leadership Appointments for its CNSide Diagnostics Subsidiary
Posted On Monday, February 24, 2025
Cellectis Presents ‘Smart CAR T’ Strategy to Enhance Efficacy Against Solid Tumors at AACR-IO 2025
Posted On Monday, February 24, 2025
UPDATE -- BioAstra Unveils "Twin Astra": Pioneering Deep-Space Medical Research Program Set to Transform Space Exploration and Earth-Based Medicine
Posted On Sunday, February 23, 2025
IO Biotech Announces New Preclinical Data for Additional Pipeline Candidate Presented at the AACR-IO Conference
Posted On Sunday, February 23, 2025
Fortrea to Add Erin L. Russell to Board of Directors
Posted On Friday, February 21, 2025
Tevogen Bio’s First Trading Year Efficiency: 600% Higher Market Cap Per Team Member, 79% Insider-Owned
Posted On Friday, February 21, 2025

Print